A New Spin on IV
The first and only connector disinfecting cap with ACTIV and passive protection that minimizes the introduction of organisms associated with unwanted and mostly preventable bloodstream infections.
ACTIV Cap Technology provides a new approach with flexible disinfecting options or what we call multi-modes. Scrubbing with friction, passive bathing and prophylactic capping protection. And it does it without technique variation. Your patient is covered. Every access. Every time.
Why ACTIV is simply better
— Jen P., RN Vascular Access Specialist
"The idea of combining a scrub-the hub action with a passive cap is brilliant and it meets both INS 2021 NeedleFree disinfection practice guidelines."
ACTIV is a leap forward in providing an effective, easy to use and cost-effective disinfecting device for connectors. Independent lab studies indicate its improved efficacy compared to existing devices.* ACTIV has also been created with a Pedi-safe design to minimize pediatric inadvertent removal. Comprehensive independent use studies indicate its intuitive to use, flexible in disinfecting modes and just simply better.
* Data on file at CleanSite Medical, Inc.
I'm a paragraph. Click here to add your own text and edit me. It’s easy. Just click “Edit Text” or double click me to add your own content and make changes to the font. I’m a great place for you to tell a story and let your users know a little more about you.
Sign up for updates and be the first to know when it's released
Hospitals are where you go to get healthy, not sick
And yet 100,000 people die from healthcare-associated infections each year in the US—unrelated to why they were initially admitted for care. That's more people who die each year from traffic accidents, breast cancer, and AIDS combined.
These hospital-associated infections are mostly preventable.
We are committed to inspiring new ways of thinking and imagining disinfection that results in purposefully designed products that support the goal of zero patient harm.
CleanSite Medical’s product portfolio is protected by a robust estate of issued patents and pending patent applications in the United States and abroad. These include U.S. Patent No. 11,065,431.
Intellectual Property Attorney, 25 years of experience in biotech, health tech, and medical devices representing investor-backed and public companies including Amgen, BioSite, and Lpath.
Co-Founder, President & Chief Innovation Officer
27 years of medical device leadership roles in sales, marketing and product development with start-up and market leading companies in infusion therapy, infection prevention, vascular access and diabetes markets.
30 years of Medical Device engineering, manufacturing and development including leadership roles at Venetec/Bard and Access Medical.
TODD AUSTIN, MD
Clinical Anesthesiologist, Medical thought leader focused on reducing HAIs throughout the clinical setting.